» Articles » PMID: 19103600

A PGC-1alpha-O-GlcNAc Transferase Complex Regulates FoxO Transcription Factor Activity in Response to Glucose

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2008 Dec 24
PMID 19103600
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic and stress response gene regulation is crucial for the survival of an organism to a changing environment. Three key molecules that sense nutrients and broadly affect gene expression are the FoxO transcription factors, the transcriptional co-activator PGC-1alpha, and the dynamic post-translational modification, O-linked beta-N-acetylglucosamine (O-GlcNAc). Here we identify novel post-translational modifications of PGC-1alpha, including O-GlcNAc, and describe a novel mechanism for how PGC-1alpha co-activates transcription by FoxOs. In liver, in cultured cells, and in vitro with recombinant proteins, PGC-1alpha binds to O-GlcNAc transferase and targets the enzyme to FoxOs, resulting in their increased GlcNAcylation and increased transcriptional activity. Furthermore, glucose-enhanced activation of FoxO1 occurs via this PGC-1alpha-O-GlcNAc transferase-mediated GlcNAcylation. Therefore, one mechanism by which PGC-1alpha can serve as a co-activator of transcription is by targeting the O-GlcNAc transferase to increase GlcNAcylation of specific transcription factors important to nutrient/stress sensing and energy metabolism.

Citing Articles

The post-translational modification O-GlcNAc is a sensor and regulator of metabolism.

Morales M, Pratt M Open Biol. 2024; 14(10):240209.

PMID: 39474868 PMC: 11523104. DOI: 10.1098/rsob.240209.


From Fringe to the Mainstream: How ETD MS Brought O-GlcNAc to the Masses.

Udeshi N, Hart G, Slawson C Mol Cell Proteomics. 2024; 23(11):100859.

PMID: 39414231 PMC: 11609545. DOI: 10.1016/j.mcpro.2024.100859.


Commercially available PGC-1α antibodies vary greatly in specificity and sensitivity.

Galipeau M, Schmitt C, Baldwin C, Gunes A, Estall J MicroPubl Biol. 2024; 2024.

PMID: 39247789 PMC: 11380096. DOI: 10.17912/micropub.biology.001268.


Forkhead box O1 in metabolic dysfunction-associated fatty liver disease: molecular mechanisms and drug research.

Sha X, Zou X, Liu S, Guan C, Shi W, Gao J Front Nutr. 2024; 11:1426780.

PMID: 39021599 PMC: 11253077. DOI: 10.3389/fnut.2024.1426780.


Roles of O-GlcNAcylation in Mitochondrial Homeostasis and Cardiovascular Diseases.

Qiu Z, Cui J, Huang Q, Qi B, Xia Z Antioxidants (Basel). 2024; 13(5).

PMID: 38790676 PMC: 11117601. DOI: 10.3390/antiox13050571.


References
1.
Ngoh G, Watson L, Facundo H, Dillmann W, Jones S . Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition. J Mol Cell Cardiol. 2008; 45(2):313-25. PMC: 2610867. DOI: 10.1016/j.yjmcc.2008.04.009. View

2.
Hu Y, Suarez J, Fricovsky E, Wang H, Scott B, Trauger S . Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. J Biol Chem. 2008; 284(1):547-555. PMC: 2610513. DOI: 10.1074/jbc.M808518200. View

3.
Brunet A, Bonni A, Zigmond M, Lin M, Juo P, Hu L . Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999; 96(6):857-68. DOI: 10.1016/s0092-8674(00)80595-4. View

4.
Schroeder M, Shabanowitz J, Schwartz J, Hunt D, Coon J . A neutral loss activation method for improved phosphopeptide sequence analysis by quadrupole ion trap mass spectrometry. Anal Chem. 2004; 76(13):3590-8. DOI: 10.1021/ac0497104. View

5.
Puigserver P, Adelmant G, Wu Z, Fan M, Xu J, OMalley B . Activation of PPARgamma coactivator-1 through transcription factor docking. Science. 1999; 286(5443):1368-71. DOI: 10.1126/science.286.5443.1368. View